Disease-free survival | ||||||
---|---|---|---|---|---|---|
Variable | Univariate | Multivariate | ||||
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Tumor size (≧2 cm vs <2 cm) | 6.7 | 2.68–16.72 | <0.0001 | 4.49 | 1.56–12.74 | 0.0047 |
Nodal status (+ vs -) | 4.79 | 2.73–8.38 | <0.0001 | 4.1 | 2.18–7.74 | <0.0001 |
Nuclear grade (Grade 3 vs 1–2) | 3.96 | 2.32–6.76 | <0.0001 | 1.69 | 0.92–3.13 | 0.094 |
CENP-F (positive vs negative) | 3.92 | 2.19–7.03 | <0.0001 | 2.94 | 1.51–5.72 | 0.0015 |
p53 (positive vs negative) | 2.35 | 1.36–4.09 | 0.0024 | 1.38 | 0.75–2.52 | 0.3 |
Ki67 (10% ≦ vs 10% >) | 2.25 | 1.36–3.72 | 0.0016 | 2.05 | 1.18–3.56 | 0.011 |
HER2 (3+,FISH+ vs 0,1+,2+(FISH-)) | 2.11 | 1.07–4.16 | 0.031 | 1.79 | 0.84–3.8 | 0.13 |
ER (positive vs negative) | 1.54 | 0.94–2.52 | 0.087 | n/a | ||
Overall survival | ||||||
Univariate | Multivariate | |||||
Variable | HR | 95% CI | p-value | HR | 95% CI | p-value |
Nodal status (+ vs -) | 9.83 | 2.58–15.71 | 0.0041 | 11.88 | 1.45–97.09 | 0.021 |
Nuclear grade (Grade 3 vs 1–2) | 3.73 | 1.25–11.15 | 0.0019 | 2.51 | 0.72–8.04 | 0.15 |
CENP-F (positive vs negative) | 3.35 | 1.05–10.72 | 0.042 | 2.05 | 0.52–8.09 | 0.31 |
Tumor size (≧2 cm vs <2 cm) | 2.28 | 1.3–3.99 | 0.0039 | 1.37 | 0.72–2.64 | 0.34 |
HER2 (3+,FISH+ vs 0,1+,2+(FISH-)) | 3.02 | 0.84–10.85 | 0.09 | n/a | ||
Ki67 (10% ≦ vs 10% >) | 2.22 | 0.78–6.36 | 0.13 | n/a | ||
p53 (positive vs negative) | 1.71 | 0.48–6.13 | 0.41 | n/a | ||
ER (positive vs negative) | 1.26 | 0.44–3.62 | 0.67 | n/a |